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Abstract
Background: Uridine (Ur) and hypoxanthine (Hx) are the major end products of ischemic
nucleotide breakdown in the human heart. Hypoxanthine is further metabolized to uric acid
(UA). The aim of the study was the evaluation of whether changes in nucleotide concentrations
during exercise correlate with electrocardiography (ECG) changes, and the severity of coronary
artery disease (CAD).
Methods: Twenty-nine males with CAD and 11 controls without CAD (mean age 56.1 vs.
51.45) were subjected to treadmill exercise. The test was considered positive if ECG showed
more then 1 mm ST segment depression. Venous blood samples taken before and 10 minut
after the exercise were analysed by high performance liquid chromatography.
Results: Twenty-two out of 29 patients with CAD and 6 of 11 in the control group had
abnormal exercise stress tests according to ECG criteria only. Mean DUr was positive in the CAD
group and negative in the control group (0.45 SEM ± 0.09 mM/L vs. –0.43 SEM ± 0.21 mM/L,
p < 0.0001). DUA was positive in the CAD group (15.31 SEM ± 5.52 mM/L) and negative in
the control group (15.31 SEM ± 5.52 mM/L vs. –48.18 SEM ± 13,8  mM/L, p < 0.00001);
Hx increased in both groups, and the change was not significantly different. Correlations of
CAD-index with ST depression, DUr and DUA, were: r = 0.43 (p < 0.005), r = 0.62 (p < 0.001),
and r = 0.39 (p < 0.01), respectively. Sensitivity of any increase of uridine was superior to
1.5 mm ST depression during exercise.
Conclusions: Blood Ur and UA concentration changes during exercise correlate with severity
of CAD. We observed slightly greater accuracy of uridine change in comparison to ST changes,
thus being a possible new tool in diagnosis of CAD. (Cardiol J 2007; 14: 573–579)
Key words: exercise stress test, coronary artery disease, uridine, hypoxanthine,
uric acid, pyrimidine and purine catabolism in the human heart
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Introduction
Despite the decreasing morbidity observed in
developed countries in recent decades, the number
of patients in Poland with angina pectoris suspect-
ed of coronary artery disease (CAD) is still high [1].
The number of deaths before arrival to hospital is
very high, and in about 70% of them, CAD is the
cause [2]. The symptomatology of this common dis-
ease is very complex, and noninvasive investiga-
tions still lack either sufficient sensitivity or spe-
cificity or are just too expensive for broad applica-
tion. It is still important to develop easy to perform
and inexpensive tests in order to meet the needs
of current practice to decide whether patients
should be referred to interventional cardiologists or
start intensive medical treatment (including stat-
ins for life), even if total cholesterol is within the
“normal” range.
Experimental studies performed in recent
years have established that ischemia induces the
release of purine and pyrimidine catabolites. They
also identified several fundamental cell-specific,
organ-related or species-dependent differences. It
has been established that the main purines released
from cardiomyocytes are adenosine and inosine.
Further catabolic degradation of these nucleosides
takes place in the endothelium, erythrocytes, liver
and intestines. The uric acid is the main end prod-
uct [3].
The breakdown of pyrimidines proceeds in
parallel with purines and has a specific pattern in
the human heart [4, 5]. Due to the high activity of
cytidine deaminase and very low (or absent) activ-
ity of uridine phosphorylase, the main catabolite
released from cardiomyocytes is uridine, which is
fairly stable in the circulation (minutes) in contrast
to hypoxanthine which is further catabolised to uric
acid. Although uridine is not metabolized in the
heart — human liver and intestines have some ca-
pacity for the breakdown of this nucleoside so that
not uridine but its catabolite, uracil, is produced. In
addition, during vigorous exercise, blood flow in
visceral circulation is reduced. Uridine could there-
fore be a relatively specific marker of ischemic nu-
cleotide breakdown in the heart. In our former stud-
ies, we observed that arterial measurements of
hypoxanthine and uridine were sensitive markers
of cardiac ischemia produced during prolonged
(3 min) occlusion of coronary arteries during per-
cutaneous transluminal coronary angioplasty
(PTCA) [6].
The aim of this study was to evaluate the
change of concentration in venous blood uridine
(Ur), hypoxanthine (Hx) and uric acid (UA) during
exercise stress tests among patients with CAD con-
firmed by coronarography.
Methods
Patients
This study was approved by the local Ethics
Committee of the Medical University of Gdansk
(TKEBN/406/98). We investigated only men in or-
der to make the groups as homogenous as possi-
ble. Table 1 presents the clinical characteristics of
our subjects. Forty men participated in the study.
Twenty-nine patients with angiographically con-
firmed CAD and 11 controls without CAD: either
free of the symptoms of the disease without family
history of CAD or truly excluded CAD in coronarog-
raphy performed among 3 patients with modest ST
depression and clinically inconclusive exercise
stress test. Their age range was 35–70.
Coronarography and
coronary artery disease index
Coronarography was performed in a typical way
and we analysed stenoses on the basis of non quanti-
tive assessment. Severity of coronary atherosclerosis
was indexed according to a slightly modified Jenkins
scale depending on the percentage narrowing of the
vessel lumen [7]: 0–50% — 1 point; 51–75% —
2 points; 76–99% — 3 points; 100% — 4 points.
Table 1. Clinical characteristics.
Coronary artery disease group (n = 29) Control group (n = 11)
Age (years) 56.14±1.52 51.45±2.44
Body mass index [kg/m2] 28.09±0.53 25.68±0.48
Systolic blood pressure [mm Hg] 135.5±3.86 137.27±5.65
Diastolic blood pressure [mm Hg] 82.24±2.17 83.18±2.8
Total cholesterol [mg/dl] 237±8.89 216±7.62
Left ventricular ejection fraction (%) 57.17±2.41 69.5±1.01
Data shown are means ± SEM
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The index is a sum of points obtained for maxi-
mal stenosis in each of the three main coronary ar-
teries. Maximum index for one patient is 12. Patients
with left main disease were not included the study.
Study protocol
The patients fasted, and the exercise stress
tests (EST) were performed in the morning. 0.8 ml
venous blood sample was taken before EST for pu-
rine and pyrimidine catabolism end products. Symp-
toms-limited treadmill EST was performed accord-
ing to Bruce (or modified Bruce protocol when nec-
essary), with angina pectoris measured in 10 grade
Borg scale (for safety reasons in our study, the
maximum grade was 7) [8], ST deviation in mm, and
workload in METs on a Marquette Case 15 tread-
mill. The test was regarded abnormal if ST was
depressed more than 1 mm 80 ms from J point. Ten
minutes after cessation of exercise, a 0.8 ml venous
blood sample was taken. The blood was immediately
deproteinised and the extracts were stored deep
frozen for further analysis of purine and pyrimidine
catabolism end products.
Metabolic determinations
End products of purines and pyrimidine catab-
olism were analysed using the high performance
liquid chromatography (HPLC) system described in
detail previously [9]. An analytic column (reverse
phase) 0.49/15 cm packed with 3 mm BDS-Hypersil
with 0.5 cm precolumn was used. Buffer A was 150 mM
KH2PO4 with 150 mM KCl at pH 6.0. Buffer B was
prepared by adding 15% acetonitrile to buffer A.
Separation was carried out using the following lin-
ear step gradient: 0 min — 0% B, 0.1 min — 6% B,
3 min — 6% B, 5.5 min — 50% B, 8 min — 100% B,
9.4 min — 100% B, 9.5 min — 0% B, 13 min — 0% B.
Time between injections was 13.5 min. The
amounts in the samples were calculated using ex-
ternal standard calibration procedure.
Statistical analysis
The data was analysed with Statistica 7.0
(StatSoft). Pre- and post-exercise differences in
concentrations of Ur, Hx and UA were calculated
and compared. We calculated the means of chang-
es of hypoxanthine, uric acid and uridine and com-
pared them between the investigated groups. Once
we confirmed the statistically significant differenc-
es between the means of those changes, the Pear-
son’s linear correlations were calculated separate-
ly for each biochemical and clinical parameter in
both study groups. In order to evaluate the corre-
lation of clinical parameters with the biochemical
changes, we preformed multistep logistic regres-
sion analysis with sequential removal of the least
important clinical parameters which influenced de-
pendant biochemical variables (eg. Ur, Hx and UA).
Finally, we also calculated the predictive (diagnos-
tic) value of the measured clinical and biological
parameters with different cut-off values.
Results
The mean CAD index in the study group was
6.34, which corresponds to the significant narrow-
ing of at least two coronary vessels. Assumed (or
true with negative coronarography) CAD index in
the whole control group was zero. We found a sig-
nificant increase of uridine during EST in the CAD
group in comparison to the controls. The mean
change in blood uridine (DUr) was positive in the
CAD group after EST (0.45 SEM ± 0.09 mM/L) and
negative in the control group (–0.43 SEM ±
± 0.21 mM/L, p < 0.0001; Fig. 1). After EST, hy-
poxanthine increased in both groups, and the change
(DHx) was not significantly different between CAD
and controls (1.83 SEM ± 0.45 mM/L vs. 2.66 SEM ±
± 0.53 mM/L; NS; Fig. 2). Uric acid change (DUA)
differed statistically significantly: DUA was positive
in the CAD group (15.31 SEM ± 5.52 mM/L) and neg-
ative among the controls (–48.18 SEM ± 13.87 mM/L;
p < 0.00001; Fig. 3).
Mean ST change between the groups was sig-
nificant (–1.92 SEM ± 0.18 mm vs. –0.92 SEM ±
± 0.26 mm; p < 0.0007; Fig. 4).
Figure 1. Comparison of uridine changes between co-
ronary artery disease (CAD) group and control group
(p < 0.0001).
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change and the CAD index Borderline statistical
significance was observed for UA change.
The strongest correlation was observed for
Angina score and CAD index (r = 0.66; p < 0.05;
Fig. 5). ST change was not significantly related to
UA change (r = –0.26; NS) and similarly uridine was
not significantly related to ST changes (r =–0.07; NS).
Of note is the lack of a statistically significant
correlation between ST depression and angina. In
addition, correlation of uridine change with angina
was rather weak (r = 0.22; NS).
In multiple regression analysis, we found a sig-
nificant relation of uridine, ST depression and an-
gina Borg score to the CAD index, and the strong-
est dependence was observed for uridine, as shown
in Table 3.
The final calculations were made in order to
assess the diagnostic value of measuring the urid-
ine change in venous blood before and after EST.
The predictive (diagnostic) value of uridine
change in venous blood is presented in Table 4.
Figure 2. Comparison of hypoxanthine changes betwe-
en coronary artery disease (CAD) group and control
group (NS).
Figure 3. Comparison of uric acid changes between
coronary artery disease (CAD) group and control group
(p < 0.0002).
Correlation coefficients of CAD-index with ST
depression, change in Ur and change in UA were:
r = –0.43 (p < 0.005), r = 0.62 (p < 0.001) and
r = 0.39 (p < 0.01), respectively (Table 2).
Significant (negative) correlation was observed
between ST depression during EST and CAD-in-
dex and significant (positive) between uridine
Figure 4. Comparison of ST changes between coronary
artery disease (CAD) group and control group
(p < 0.0007).
Table 2. Correlation of coronary artery disease
index with ST change and biochemical parame-
ter change.
Parameters r p
ST depression 0.43 < 0.005
DUr 0.62 < 0.001
DUA 0.39 < 0.01
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Twenty-two out of 29 patients with CAD had posi-
tive exercise stress tests according to standard
electrocardiography (ECG) criteria indicating a sen-
sitivity of 79% and specificity 36%. The mean
change in blood uridine was positive in the CAD
group (0.45 ± 0.09 mM/L, mean ± SEM) and nega-
tive in the control group (0.43 ± 2.16 mM/L; p <
< 0.0001). Any positive change in uridine concen-
tration indicates CAD with sensitivity of 75% and
specificity 72%. Setting cut-off values of ST depres-
sion to 1.5 mm and DUr to 0.1 mm/L resulted in both
becoming more valuable for suspecting or ruling out
CAD but still in favour of uridine.
Discussion
The major finding of this study is the demon-
stration of the potential diagnostic value of moni-
toring uridine concentration changes during tread-
mill exercise stress test for detection or ruling out
of coronary artery disease. Among patients with
angiographically confirmed CAD, a statistically sig-
nificant change of concentration in peripheral blood
of uridine was observed after EST in comparison
to the control group. Uridine concentration change
after EST showed a correlation with the CAD in-
dex, comparable to the correlation of ST depression
during exercise.
Some differences between patients and con-
trols were observed for age, body mass index (BMI)
and ejection fraction (EF). The study group was
older, but this minor age difference would not
change the probability of having CAD according to
assessment based on gender, age and presence of
angina [10, 11]. Body mass index was higher in the
study group, which corresponds to the risk factors.
Lower EF was a result of CAD and previous myo-
cardial infarction among some patients. Of note is
the lack of statistical difference in total cholesterol
between the groups.
About 50% of patients referred for a submaxi-
mal (at 85% of heart limit) EST with ECG assess-
ment do not obtain a definite answer e.g. test neg-
ative or positive for ischemia, mostly because of
beta adrenergic blockade, poor exercise tolerance
or hypertonic reaction. Another subset of patients
had nonspecific ECG changes at rest with border-
line ST shift during exercise, without angina or with
atypical chest pain. In our study, only the ECG crite-
ria were analysed. In the majority of patients (approx
70% — our own data), the treadmill exercise stress
is clinically appropriate and provides sufficient data
even if the heart limit was not obtained. As well
as ST changes, the same attention is attributed
Figure 5. Correlation of coronary artery disease (CAD)
indices with Borg scale.
Table 3. Multiple regression analysis of associa-
tion of clinical and biochemical variables and
coronary artery disease index.
Independent Statistical
variable  significance (p)
DUr < 0.0001
ST < 0.004
Angina (Borg) < 0.003
DUA NS
MET NS
Age NS
Body mass index NS
Ejection fraction NS
Table 4. Diagnostic accuracy.
Cut-off criteria Sensitivity Specificity PPV NPV OR
ST depression 1 mm 79% 36% 76% 40% 1.24
ST depression 1.5 mm 68% 81% 91% 50% 3.79
DUr > 0.0 mm/L 75% 72% 88% 53% 2.78
DUr > 0.1 mm/L 82% 91% 96% 66% 9.1
PPV — positive predictive value; NPV — negative predictive value; OR — odds ratio (positive likelihood ratio)
578
Cardiology Journal 2007, Vol. 14, No. 6
www.cardiologyjournal.org
to exercise capacity, presence of angina and blood
pressure behaviour during exercise, including the
incidence of arrhythmia or abnormalities of conduc-
tion, according to guidelines [11].
The next step in diagnosing CAD usually includes
either single photon emission computed tomogra-
phy (SPECT) cardiac examination (Thallium 99)
or dobutamine stress echocardiography. High
resolution computed tomography (Cardio-CT) or
magnetic resonance imaging investigation could be
other possibilities of noninvasive assessment of the
presence of coronary arteriosclerosis.
Over the past 20 years, we have observed an
improvement in the understanding of the basic
metabolism of the human heart. This may provide
the basis for distinguishing the true heart ischemia
from other benign causes of chest pain. Measure-
ment of cardiac troponins, I or T, among patients
experiencing short-term heart ischemia seems to
be of limited value in this setting, as these large
molecules can only be released if the cell membrane
is damaged after prolonged severe ischemia. They
serve, therefore, as the confirmation of the need for
rapid intervention in acute syndromes, not as the
alternative for inconclusive exercise ECG test [12].
There were, however, investigations showing that
short ischemia can induce the release of small amounts
of troponins into coronary sinus blood [13, 14].
In contrast to protein markers, the heart re-
leases nucleotide catabolites immediately after dis-
cordance of blood supply, and demand occurs well
before any cellular membrane damage starts. The
measurements of changes in catabolite levels in
coronary sinus, arterial blood or in peripheral vein
blood could be clinically useful, if interpreted in
combination with clinical events. The most conven-
ient in the setting of the exercise stress test seems
to be venous blood taken at peak exercise (or im-
mediately after it) with consecutive samples taken
in a timely manner within 5–10 or maximum
20 minutes. In earlier studies, we investigated the
release of hypoxanthine, uric acid and uridine in ar-
terial and venous blood during PTCA, which served
as the model of ischemia, in order to asses the val-
ue of sampling venous blood. We noticed that
venous blood samples in resting patients within
10 minutes after controlled 2–3 minute ischemia
were equally valuable as arterial samples only for
uridine [6].
This work was undertaken assuming that uri-
dine metabolism is relatively slow in circulation, and
our results confirmed this among the exercised
patients. The release of uridine seems to be an early
and specific catabolite indicative for human heart
ischemia. The presented results show that exercise
induced increase in uridine concentration correlat-
ed better with severity of arteriosclerosis than ST
depression. Not unexpectedly, ST depression dur-
ing EST was significantly greater in patients with
CAD, and ST depression correlated significantly
(negative correlation) with severity of coronary
atherosclerosis (CAD index). However, there was
no correlation between uridine concentration
change and ST change. This is a consequence of
different mechanisms responsible for both effects,
as ST was depressed significantly also among pa-
tients without any signs of CAD in the control group
where CAD was excluded in angiography among
patients in doubt, and not all patients in the CAD
group experienced angina. Simultaneous ST de-
pression and the occurrence of typical angina pec-
toris are probably the most sensitive and specific
noninvasive signs of heart ischemia. In our study,
the correlation of angina with CAD was strong.
Hypoxanthine increased in both groups, and this
change was not significantly different between them.
It is possible that skeletal muscle release of hypox-
anthine during exercise masked the cardiac hypox-
anthine release, and therefore no difference was
observed. This contrasts to the uric acid changes
where, in the control group, uric acid change de-
creased statistically significantly 10 minutes after
cessation of exercise in comparison to CAD patients.
The mismatch in uric acid and hypoxanthine chang-
es is difficult to explain, as uric acid is a metabolite
of hypoxanthine. However, uric acid concentration
change may not only indicate its increased produc-
tion but also its redistribution between intracellular
and vascular space. Lower pH in the ischemic regions
would trigger release of uric acid from cardiac cells
related to changes in the ionization status of uric acid.
Conclusions
In summary, among patients with CAD con-
firmed in angiography, a statistically significant
change of concentration of uridine in peripheral
blood was observed after treadmill exercise in com-
parison to the control group. Uridine concentration
change after EST shows a correlation with the se-
verity of coronary arteriosclerosis, comparable to
the correlation of ST depression during exercise.
Analysing uridine concentration changes could be
a useful diagnostic investigation for evaluating the
presence of CAD, but further studies are needed
to ascertain its clinical value. The lack of correla-
tion of uridine change with ST depression is not sur-
prising, as ST depression is sometimes present
579
Sławomir Burakowski et al., Exercise stress test and comparison of ST change in patients with CAD
www.cardiologyjournal.org
without arteriosclerosis, and in contrast we often
do not observe ST depression among patients with
severe CAD (e.g. triple vessel disease).
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